Training Grant in Cancer Prevention and Control in Priority Populations

The overarching goal of the Cancer Prevention and Control (CPC) in Priority Populations postdoctoral research training program is to launch the careers of a new generation of clinical and non-clinical researchers who are prepared to apply a multidisciplinary approach to CPC research targeting priority populations. The program will recruit candidates who show promise as future multidisciplinary CPC investigators; provide outstanding mentorship; foster a multidisciplinary team science environment; and facilitate the attainment of academic career and life skills needed to pursue and sustain long-term success as independent investigators.

We offer a two-year post-doctoral Research Fellowship in Cancer Prevention and Control with a focus on priority populations who are disproportionately vulnerable to develop and/or suffer from cancer. Ideal candidates are physicians who have completed an accredited clinical residency or graduates of PhD or equivalent programs in relevant fields (e.g., clinical psychology, epidemiology, health psychology, anthropology). All fellows will conduct mentored research and will be eligible to earn a Master of Science in Clinical Research (MSCR) through completion of a tailored curriculum integrating biological, medical, psychological, epidemiologic, behavioral, and community perspectives in cancer prevention and control. Stipend and tuition are provided along with an allowance for travel and research expenses. We seek applicants with a commitment to our program's aims who have aspirations for an academic research career.

The CPC Research Training Program includes over 25 faculty researchers and numerous students and research staff. Research foci include cancer prevention and screening, health disparities, comparative effectiveness, behavioral and health psychology, genetics, cancer education, molecular epidemiology, symptom control, palliative care, and more. This fellowship is being offered jointly through the Division of General Internal Medicine and the Tisch Cancer Institute at the Icahn School of Medicine at Mount Sinai.

The program’s goals are to: 1) Provide a tailored curriculum integrating biological, medical, epidemiologic, behavioral, and community perspectives in CPC research in priority populations; 2) Promote interdisciplinary approaches to CPC research; and 3) Foster multidisciplinary research careers in CPC among trainees through mentored research. Read more about our curriculum.

The core mentoring faculty is multidisciplinary, including experts in cancer prevention and screening, health disparities, comparative effectiveness, behavioral psychology, genetics, molecular epidemiology, and palliative care. Read about our mentors

Suzanne Vang, PhD is a T32 Postdoctoral Fellow in the Department of Population Health Science and Policy at the Icahn School of Medicine at Mount Sinai. Her research focuses on investigating and addressing cancer screening disparities in medically underserved populations, particularly in Asian Pacific Islanders, Latinas, and African Americans. Dr. Vang has recently been awarded a Postdoctoral Fellowship from the American Cancer Society to develop and pilot test culturally- and linguistically-tailored decision aids to improve breast density care for Latina women with high breast density. She received her Ph.D. in October 2017 from Columbia University.

Deborah Marshall, MD, MSCR is a chief resident in Radiation Oncology and a T32 and Holman Pathway research fellow at the Icahn School of Medicine at Mount Sinai.  After graduating from the University of California, Berkeley with a degree in comparative ethnic studies and working in immigration law, Dr. Marshall pursued her medical training and a Master's degree in clinical research at the University of California, San Diego School of Medicine.  She then completed her transitional year internship at Memorial Sloan Kettering Cancer Center.  As a research fellow, she now leads a multidisciplinary team studying female sexual toxicity after pelvic radiotherapy supported by grants from the Patty Brisben Foundation, NRG Oncology, and the Conquer Cancer Foundation of ASCO.  Her clinical scientific research focuses on clinical and population-based radiation toxicity outcomes in priority populations including women and persons with HIV. Her social scientific research focuses on financial conflicts of interest in medicine and health policy.

Stacyann Bailey, PhD is a T32 Fellow in Cancer Prevention and Control at Mount Sinai. She earned her doctoral degree in biomedical engineering from Rensselaer Polytechnic Institute and completed her undergraduate studies at the City College of New York. Dr. Bailey is trained in the assessment of bone matrix quality and mechanical properties, which degrades with aging and diseases. She is currently investigating the clinical and pathological characteristics associated with knowledge and perceived risk of osteoporosis and adherence to behaviors that promote bone health in older Breast Cancer patients. Her research interest lies in the development of new strategies to predict, manage, and mitigate pathological fractures in cancer patients.

Amanda Leiter MD, MS is a clinical faculty member and research fellow in the Division of Endocrinology, Diabetes, and Bone Disease as well as a new fellow with DGIM’s Cancer Prevention and Control Fellowship. She received her MD and MS in Clinical Research from the Icahn School of Medicine at Mount Sinai. Then she completed an internal medicine residency and clinical endocrinology fellowship at Mount Sinai Hospital. Her research interests relate to the intersection of metabolic disease and cancer-- how metabolic disease impacts cancer outcomes, and vice versa, how cancer diagnosis and treatments impact metabolic diseases.

Melissa Mazor, RN, MS, PhD is an Instructor and T32 Cancer Prevention and Control Fellow in the Mount Sinai Division of General Internal Medicine. Prior to joining the faculty at Mount Sinai, Melissa was a postdoctoral fellow at NYU and the VA Quality Scholar Program in the UCSF Division of Geriatrics. Melissa received her PhD and MS in nursing from University of California, San Francisco and BA in psychology from the University of California, Berkeley. Her research investigates cancer survivorship outcomes in vulnerable populations. She is particularly interested in developing and implementing culturally sensitive, community-based interventions to mitigate distress, symptom burden, and survivorship outcomes in underserved Black, Latinx, and Asian American cancer survivors. Melissa is the principal investigator of a qualitative study examining distress and symptom burden in Black female cancer survivors. She is also the project lead for the ‘Environmental Scan for Mental Health Screening for Asian American Cancer Survivors’ at New York University funded through the Cancer Prevention and Control Research Network.

This is a non-ACGME program.

We accept applications in a rolling fashion in the fall-winter preceding the fellowship start date (July 1 of each year). To apply, submit the following here

  1. A cover letter describing yourself and your interests in the CPC post-doctoral fellowship training; 
  2. Your curriculum vitae; 
  3. Information about your citizenship and/or visa status. 

Three letters of recommendation will be required after the initial screening process, though these can be sent initially if desired. Letters of recommendation should be from faculty members who are familiar with the applicant's qualifications. One of these letters must be from the director of the current or most recent clinical training program. 

Please direct all inquiries to: 

Name: Jaclyn Verity
Title: Project Manager
Address: 1216 Fifth Avenue, Suite 552, New York, NY 10029
Phone: 212-824-7981

Minority Applicants 
We encourage members of underrepresented minority groups to apply. Many research projects conducted by the faculty focus on the care of minority or underserved populations.